Carasent AB (CARA.ST)
Gothenburg, SE
Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient communication and business intelligence. The company was founded in 1997 and is headquartered in Gothenburg, Sweden.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.64% | -2.10% | -2.51% | -3.32% | -17.23% | -13.06% | -13.54% | +56.38% | -38.03% | +275.81% | +94.17% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Software - Application: +13.0%+28.8% ★ Q2'26: +17.9% (vs Q2'25)
-
EPS growth Software - Application: +28.6%+189.3% ★ Q2'26: +53.1% (vs Q2'25)
-
FCF margin FCF growth · Software - Application: +45.3%+0.8% Q2'26: +16.4% (vs Q2'25)
-
EBIT margin Software - Application: +9.4%+2.7% Q2'26: -2.8% (vs Q2'25)
-
ROIC Software - Application: +7.5%+1.4% Q2'26: -1.4% (vs Q2'25)
-
Share dilution Software - Application: +0.0%-4.1% ★ Q2'26: +7.0% (vs Q2'25)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×0.44× ★ Q2'26: 0.48× (vs Q2'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
243.98M
est: 237.25M (+2.8%)
|
266.90M
est: 263.85M (+1.2%)
|
343.82M
est: 313.09M (+9.8%)
|
404.67M
401.76M – 407.58M
+29.2% YoY
|
494.44M
487.97M – 500.90M
+22.2% YoY
|
556.98M
556.74M – 557.22M
+12.6% YoY
|
626.96M
622.45M – 631.47M
+12.6% YoY
|
| EBITDA |
2.91M
est: 6.00M (-51.4%)
|
16.99M
est: 38.03M (-55.3%)
|
73.34M
est: 45.13M (+62.5%)
|
58.32M
57.91M – 58.74M
+29.2% YoY
|
71.26M
70.33M – 72.20M
+22.2% YoY
|
80.28M
80.24M – 80.31M
+12.6% YoY
|
90.36M
89.71M – 91.01M
+12.6% YoY
|
| EBIT |
-47.98M
est: -30.30M (-58.4%)
|
-42.20M
est: -6.09M (-593.0%)
|
9.44M
est: -7.23M (+230.6%)
|
-9.34M
-9.41M – -9.27M
-29.2% YoY
|
-11.41M
-11.56M – -11.26M
-22.2% YoY
|
-12.86M
-12.86M – -12.85M
-12.6% YoY
|
-14.47M
-14.58M – -14.37M
-12.6% YoY
|
| Net Income |
-46.45M
est: -6.20M (-649.3%)
|
-40.97M
est: 5.98M (-784.9%)
|
34.67M
est: 11.39M (+204.5%)
|
30.98M
30.69M – 31.27M
+172.0% YoY
|
64.89M
64.29M – 65.50M
+109.5% YoY
|
94.96M
86.96M – 102.97M
+46.3% YoY
|
126.85M
125.66M – 128.03M
+33.6% YoY
|
| SGA |
29.15M
est: 58.58M (-50.3%)
|
54.79M
est: 51.10M (+7.2%)
|
22.50M
est: 60.63M (-62.9%)
|
78.37M
77.80M – 78.93M
+29.2% YoY
|
95.75M
94.50M – 97.01M
+22.2% YoY
|
107.87M
107.82M – 107.91M
+12.6% YoY
|
121.42M
120.54M – 122.29M
+12.6% YoY
|
| EPS |
-0.60
est: -0.09 (-600.1%)
|
-0.56
est: 0.09 (-749.1%)
|
0.50
est: 0.16 (+204.5%)
|
0.45
0.44 – 0.45
+172.0% YoY
|
0.94
0.93 – 0.94
+109.5% YoY
|
1.37
1.25 – 1.49
+46.3% YoY
|
1.83
1.81 – 1.85
+33.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-28 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-27 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-26 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-25 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-22 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-21 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-20 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-19 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-18 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-15 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-13 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-12 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-11 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-05 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 2/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 2/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 2/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 2/5 | 5/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - International Small Cap ETF DFIS | 0.00% | 183.6K | 0.39% |
| 2 | Dimensional - International Core Equity Market ETF DFAI | 0.00% | 170.6K | 0.18% |
| 3 | State Street SPDR Portfolio Europe ETF SPEU | 0.00% | 6.6K | 0.07% |
| 4 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 73.3K | 0.22% |
| 5 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 52.6K | 0.28% |
| 6 | Dimensional International Sustainability Core 1 ETF DFSI | 0.00% | — | 0.24% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Daniel Ohman | Chief Executive Officer | 3M | male |
| Svein Martin Bjornstad | Chief Financial Officer | 2M | male |
| Advocate Jon Schultz | Legal Counsel | 45.0K | — |
| Anna Holmen Larsson | People and Culture Manager | — | female |
| Stefan Jernberg | Chief Compliance Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CARA.ST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
